# XTL Biopharmaceuticals Ltd: Form 6-K, filed Nov 15, 2023

- Company: [XTL Biopharmaceuticals Ltd](/companies/xtlb.md) (CIK 1023549)
- Form: 6-K
- Filed: 2023-11-15
- Accepted by EDGAR: Nov 15, 2023, 15:29 ET
- Period: 2023-11-15
- Accession: 0001213900-23-087344
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1023549/000121390023087344/ea188494-6k_xtlbiopharma.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1023549/000121390023087344/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1023549/000121390023087344/ea188494-6k_xtlbiopharma.htm

Filed Nov 15, 2023.
Source: SEC EDGAR, the filing index for accession 0001213900-23-087344. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.